Vincent Perrone | Senior Director of Investor Relations |
Liz Barrett | President and Chief Executive Officer |
Mark Schoenberg | Chief Medical Officer |
Jeff Bova | Chief Commercial Officer |
Molly Henderson | Chief Financial Officer |
Boris Peaker | Cowen |
Christopher Howerton | Jefferies |
Ram Selvaraju | H.C. Wainwright |
Matt Kaplan | Ladenburg Thalmann |
Good morning, ladies and gentlemen, and thank you for standing by, and welcome to UroGen Pharma's Fourth Quarter and Full Year 2021 Financial Results and Business Update Conference Call. It is now my pleasure to turn the call over to Vincent Perrone, Senior Director of Investor Relations for UroGen Pharma. Please go ahead.
Thank you, operator. Good morning everyone and welcome to UroGen Pharma's fourth quarter and full year 2021 financial results and business update conference call.